Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP248741.RAB7jCXGdpVLleYvUHaO18O8-VcY43tDRGzgIsPzOzyEk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP248741.RAB7jCXGdpVLleYvUHaO18O8-VcY43tDRGzgIsPzOzyEk130_assertion type Assertion NP248741.RAB7jCXGdpVLleYvUHaO18O8-VcY43tDRGzgIsPzOzyEk130_head.
- NP248741.RAB7jCXGdpVLleYvUHaO18O8-VcY43tDRGzgIsPzOzyEk130_assertion wasGeneratedBy ECO_0000203 NP248741.RAB7jCXGdpVLleYvUHaO18O8-VcY43tDRGzgIsPzOzyEk130_provenance.
- NP248741.RAB7jCXGdpVLleYvUHaO18O8-VcY43tDRGzgIsPzOzyEk130_assertion wasDerivedFrom befree-2016 NP248741.RAB7jCXGdpVLleYvUHaO18O8-VcY43tDRGzgIsPzOzyEk130_provenance.
- NP248741.RAB7jCXGdpVLleYvUHaO18O8-VcY43tDRGzgIsPzOzyEk130_assertion SIO_000772 10096585 NP248741.RAB7jCXGdpVLleYvUHaO18O8-VcY43tDRGzgIsPzOzyEk130_provenance.
- NP248741.RAB7jCXGdpVLleYvUHaO18O8-VcY43tDRGzgIsPzOzyEk130_assertion evidence source_evidence_literature NP248741.RAB7jCXGdpVLleYvUHaO18O8-VcY43tDRGzgIsPzOzyEk130_provenance.
- NP248741.RAB7jCXGdpVLleYvUHaO18O8-VcY43tDRGzgIsPzOzyEk130_assertion description "[Our results suggest that ATLL represents almost 50% of T-cell lymphomas in Martinique; Ss infection during ATLL seems to be linked with a high response rate to chemotherapy and prolonged survival; and P53 overexpression is observed in almost 50% of aggressive ATLL from Martinique and, even in advanced clinical subtypes, is associated with resistance to chemotherapy and short-term survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP248741.RAB7jCXGdpVLleYvUHaO18O8-VcY43tDRGzgIsPzOzyEk130_provenance.